Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GIPS II metabolic control with glucose-insulin-potassium in acute myocardial infarction
NL-OMON25522Active, not recruiting
- Sponsor
- Isala
- Start
- May 2003
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of potassium chloride, glucose and human insulin in myocardial infarction (MI) (2 arms), sponsored by Isala. Primary endpoints: 30-day mortality and 30-day cardiovascular mortality. Started May 2003; status: active, not recruiting.
02
Drugs
potassium chlorideglucosehuman insulin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NL-OMON25522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25522.